Linked Data API

Show Search Form

Search Results

1654043
registered interest false remove filter
date less than 2023-07-18more like thismore than 2023-07-18
answering body
Department of Health and Social Care more like this
answering dept id 17 more like this
answering dept short name Health and Social Care more like this
answering dept sort name Health and Social Care more like this
hansard heading Babies: Screening more like this
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health and Social Care, with reference to the APPG for Muscular Dystrophy report entitled Newborn Screening for Rare Conditions, published May 2023, what assessment he has made for the implications for his policies of the recommendation that when conditions previously rejected for newborn screening are reassessed, there should be a clear expedited process that demonstrates how gaps will be filled rather than restarting a review process each time. more like this
tabling member constituency Bootle more like this
tabling member printed
Peter Dowd more like this
uin 194872 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2023-07-24more like thismore than 2023-07-24
answer text <p>The UK National Screening Committee (UK NSC) has published its evidence review process, which is available at the following link:</p><p><a href="https://www.gov.uk/government/publications/uk-nsc-evidence-review-process/uk-nsc-evidence-review-process" target="_blank">https://www.gov.uk/government/publications/uk-nsc-evidence-review-process/uk-nsc-evidence-review-process</a></p><p>As outlined in the process, an evidence map is commissioned first. This process deliberately builds on previous evidence and does not start again. This evidence map draws on uncertainties identified from the previous review to identify whether there has been any advancement in the evidence base for that topic before a more significant review is commissioned. The final evidence product (a map or a review) draws attention to the gaps in the evidence that mean the UK NSC cannot confidently recommend screening.</p><p>The UK NSC’s process using an evidence map is similar to a process used by the National Institute for Health and Care Excellence.</p>
answering member constituency Colchester more like this
answering member printed Will Quince more like this
question first answered
less than 2023-07-24T16:54:21.977Zmore like thismore than 2023-07-24T16:54:21.977Z
answering member
4423
label Biography information for Will Quince more like this
tabling member
4397
label Biography information for Peter Dowd remove filter